v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Collaboration revenue $ 0 $ 0 $ 7,000
Operating expenses:      
Research and development 33,756 65,742 85,697
General and administrative 18,514 23,393 26,540
Restructuring and impairment charges 6,837 1,470 6,187
Total operating expenses 59,107 90,605 118,424
Loss from operations (59,107) (90,605) (111,424)
Interest income 4,444 8,462 11,104
Other expenses (1,370) (1,593) (1,550)
Net loss $ (56,033) $ (83,736) $ (101,870)
Net loss per common share, basic (in dollars per share) $ (7.66) $ (11.49) $ (14.04)
Net loss per common share, diluted (in dollars per share) $ (7.66) $ (11.49) $ (14.04)
Weighted-average shares used to compute net loss per common share, basic (in shares) 7,316,890 7,290,245 7,255,365
Weighted-average shares used to compute net loss per common share, diluted (in shares) 7,316,890 7,290,245 7,255,365